These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37521234)

  • 41. Intralesional measles, mumps, and rubella vaccine after failure of intralesional Candida antigen for the treatment of recalcitrant pediatric warts.
    Ulschmid CM; Patel J; Pan AY; Liegl M; Holland KE
    Pediatr Dermatol; 2023; 40(6):1057-1059. PubMed ID: 37596908
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intralesional Injection of the Measles-Mumps-Rubella Vaccine into Resistant Palmoplantar Warts: A Randomized Controlled Trial.
    Rezai MS; Ghasempouri H; Asqary Marzidareh O; Yazdani Cherati J; Rahmatpour Rokni G
    Iran J Med Sci; 2019 Jan; 44(1):10-17. PubMed ID: 30666071
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Comparative Analysis of Efficacy of Intralesional Mumps-Measles-Rubella Vaccine Versus 5-Fluorouracil in the Treatment of Palmoplantar Warts.
    Sunny AS; Doshi BR
    Indian Dermatol Online J; 2022; 13(5):611-616. PubMed ID: 36304636
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intralesional injection of measles, mumps, and rubella vaccine versus cryotherapy in treatment of warts: A randomized controlled trial.
    Abd El-Magiud EM; Abd El-Samea GM; Gaber HD
    Dermatol Ther; 2020 Mar; 33(2):e13257. PubMed ID: 32031726
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intralesional Vitamin D
    Raghukumar S; Ravikumar BC; Vinay KN; Suresh MR; Aggarwal A; Yashovardhana DP
    J Cutan Med Surg; 2017; 21(4):320-324. PubMed ID: 28384048
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Efficacy and Safety of Intralesional Immunotherapy with Tuberculin Purified Protein Derivative among Cutaneous Wart Patients.
    Shrestha SB; Bhusal M; Jwarchan J; Gautam S; Shrestha PR
    J Nepal Health Res Counc; 2023 Jul; 20(4):881-885. PubMed ID: 37489671
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intralesional immunotherapy with purified protein derivative (PPD) for cryotherapy-resistant warts.
    Kaimal S; Gopinath H; Premalatha V
    Int J Dermatol; 2020 Jun; 59(6):726-729. PubMed ID: 32112396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Randomized double Blind Controlled Study Comparing the Efficacy of Intralesional MMR Vaccine with Normal Saline in the Treatment of Cutaneous Warts.
    Agrawal C; Vyas K; Mittal A; Khare AK; Gupta LK
    Indian Dermatol Online J; 2018; 9(6):389-393. PubMed ID: 30505777
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intralesional Immunotherapy with Measles Mumps Rubella Vaccine for the Treatment of Anogenital Warts: An Open-label Study.
    Sharma S; Agarwal S
    J Clin Aesthet Dermatol; 2020 Aug; 13(8):40-44. PubMed ID: 33178381
    [No Abstract]   [Full Text] [Related]  

  • 50. Intralesional immunotherapy for non-genital warts: A systematic review and meta-analysis.
    Ju HJ; Park HR; Kim JY; Kim GM; Bae JM; Lee JH
    Indian J Dermatol Venereol Leprol; 2022; 88(6):724-737. PubMed ID: 35962514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of Effectiveness and Safety of Immunotherapy of Warts with Intralesional Versus Subcutaneous MMR Vaccine: An Open Label Randomized, Parallel Group, Clinical Trial.
    Saha A; Bahalia I; Agarwal S; Banerjee A; Bandyopadhyay D
    Indian J Dermatol; 2022; 67(2):99-108. PubMed ID: 36092192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Randomized Comparative Study of MIP and MMR Vaccine for the Treatment of Cutaneous Warts.
    Kaur A; Brar BK; Kumar S; Brar SK; Boparai AS; Puri N
    Indian J Dermatol; 2021; 66(2):151-158. PubMed ID: 34188270
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial.
    Horn TD; Johnson SM; Helm RM; Roberson PK
    Arch Dermatol; 2005 May; 141(5):589-94. PubMed ID: 15897380
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intralesional Vitamin D Injection May Be an Effective Treatment Option for Warts.
    Aktaş H; Ergin C; Demir B; Ekiz Ö
    J Cutan Med Surg; 2016; 20(2):118-22. PubMed ID: 26294740
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intralesional purified protein derivative versus zinc sulfate 2% in the treatment of pediatric warts: Clinical and dermoscopic evaluation.
    Awad A; Ismael AF; Sallam M; Abdelgaber S
    J Cosmet Dermatol; 2022 Oct; 21(10):4637-4645. PubMed ID: 35212136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intralesional immunotherapy of plantar warts: report of a new antigen combination.
    Gamil H; Elgharib I; Nofal A; Abd-Elaziz T
    J Am Acad Dermatol; 2010 Jul; 63(1):40-3. PubMed ID: 20462659
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Efficacy and Safety of Intralesional Immunotherapy with Measles, Mumps, Rubella Virus Vaccine for the Treatment of Common Warts in Adults.
    Chauhan PS; Mahajan VK; Mehta KS; Rawat R; Sharma V
    Indian Dermatol Online J; 2019; 10(1):19-26. PubMed ID: 30775294
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy of Intralesional Vitamin D3 for Treatment of Verruca Vulgaris: A Randomized Control Study.
    Noureen U; Shah RR; Waqas N; Sharif S; Shah A; Rao BK
    J Clin Aesthet Dermatol; 2023 Aug; 16(8):47-50. PubMed ID: 37636250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intralesional injection of tuberculin purified protein derivative (PPD) versus measles, mumps, and rubella (MMR) vaccine in treatment of molluscum contagiosum: a comparative study.
    Zaky MS; Atallah RB; Mohyeldeen AMS; Elsaie ML
    Sci Rep; 2024 Jan; 14(1):288. PubMed ID: 38167543
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intralesional immunotherapy for the treatment of warts: A network meta-analysis.
    Salman S; Ahmed MS; Ibrahim AM; Mattar OM; El-Shirbiny H; Sarsik S; Afifi AM; Anis RM; Yakoub Agha NA; Abushouk AI
    J Am Acad Dermatol; 2019 Apr; 80(4):922-930.e4. PubMed ID: 30003983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.